SK Bioscience Co Ltd (302440) — Capital Reinvestment Ratio
SK Bioscience Co Ltd (302440) has a Capital Reinvestment Ratio of 3.44x as of September 2025, meaning it reinvests 3% of its operating cash flow (₩20.65 Billion) in capital expenditures (₩70.94 Billion). See 302440 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SK Bioscience Co Ltd Capital Reinvestment Ratio (2018–2023)
This chart tracks SK Bioscience Co Ltd's Capital Reinvestment Ratio across 5 annual periods. Check 302440 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for SK Bioscience Co Ltd (2018–2023)
Year-by-year Capital Reinvestment Ratio for SK Bioscience Co Ltd from 2018 to 2023. For live market cap and broader valuation context, see how much is SK Bioscience Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.71x | ₩29.35 Billion | ₩50.30 Billion | ▲ +2043.3% |
| 2021 | 0.08x | ₩536.59 Billion | ₩42.91 Billion | ▼ -3.2% |
| 2020 | 0.08x | ₩120.22 Billion | ₩9.93 Billion | ▼ -92.5% |
| 2019 | 1.10x | ₩21.82 Billion | ₩23.97 Billion | ▲ +159.4% |
| 2018 | 0.42x | ₩14.90 Billion | ₩6.31 Billion | — |